Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth

Prostate

Volumn 70, Issue 2, 2010, Pages 190-199

  Shyr, Chih Rong ^a,b   Tsai, Meng Yin ^b   Yeh, Shuyuan ^c   Kang, Hong Yo ^b   Chang, Yun Chao ^b   Wong, Pei Ling ^b   Huang, Chao Cheng ^b   Huang, Ko En ^b   Chang, Chawnshang ^c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Androgen receptor; Co repressor; PAX6; Prostate cancer

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR PAX6;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL REGENERATION; COLONY FORMATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO HYBRID SYSTEM; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL PROLIFERATION; CO-REPRESSOR PROTEINS; EYE PROTEINS; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; MALE; PAIRED BOX TRANSCRIPTION FACTORS; PLASMIDS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 73449131887     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21052     Document Type: Article

References (44)

1. Strachan T, Read AP. PAX genes. Curr Opin Genet Dev 1994; 4(3):427-438.
2. Ton C, Miwa H, Saunders G. Small eye (Sey): Cloning and characterization of the murine homolog of the human aniridia gene. Genomics 1992;13:251-256.
3. St-Onge L. PAX6 glucagon. Nature 1997;387:406-409.
4. Guillemot F. Cellular and molecular control of neurogenesis in the mammalian telencephalon. Curr Opin Cell Biol 2005;17(6): 639-647.
5. Dohrmann C, Gruss P, Lemaire L. Pax genes and the differentiation of hormone-producing endocrine cells in the pancreas. Mech Dev 2000;92(1):47-54.
6. Bamiou DE, Musick FE, Sisodiya SM, Free SL, Mitchell TN, Davies RA. Defective auditory interhemispheric transfer in a patient with a PAX6 mutation. Neurology 2004;62:489-490.
7. Goolsby J, Marty M, Heletz D, Chiappelli J, Tashko G, Yarnell D, Fishman P, Dhib-Jalbut S, Bever CJ, Pessac B, Trisler D. Hematopoietic progenitors express neural genes. Proc Natl Acad Sci USA 2003;100(25):14926-14931.
8. Culig Z, Steiner H, Bartsch G, Hobisch A. Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours. Endocr Relat Cancer 2005;12(2):229-244.
9. Kioussi C, O'Connell S, St-Onge L, Treier M, Gleiberman A, Gruss P, Rosenfeld M. Pax6 is essential for establishing ventraldorsal cell boundaries in pituitary gland development. Proc Natl Acad Sci USA 1999;96(25):14378-14382.
10. Bentley C, Zidehsarai M, Grindley J, Parlow A, Barth-Hall S, Roberts V. Pax6 is implicated in murine pituitary endocrine function. Endocrine 1999;10(2):171-177.
11. Robson EJ, He SJ, Eccles MR. A PANorama of PAX genes in cancer and development. Nat Rev Cancer 2006;6(1):52-62.
12. Nitta Y, Yoshita K, Satoh K, Senba K, Natagata N, Peters J, BMC. Spontaneous and radiation induxed leukemogenesis of the mouse small eye mutant, Pax6 (Sey3H). J Radiat Res (Tokyo) 2004;45(2):245-251.
13. Salem C, Markl I, Bender C, Gonzales F, Jones P, Liang G. PAX6 methylation and ectopic expression in human tumor cells. Int J Cancer 2000;87:179-185.
14. Hellwinkel OJ, Kedia M, Isbarn H, Budaus L, Friedrich MG. Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours. BJU Int 2008;101(6):753-757.
15. Ballestar E, Paz M, Valle L, Wei S, Fraga M, Espada J, Cigudosa J, Huang T, Esteller M. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J 2003;22(23):6335-6345.
16. Zhou YH, Wu X, Tan F, Shi YX, Glass T, Liu TJ, Wathen K, Hess KR, Gumin J, Lang F, Yung WK. PAX6 suppresses growth of human glioblastoma cells. J Neurooncol 2005;71:223-229.
17. Myers D, Hu Y, Teng Y, Siegel E, Wu X, Panda K, Tan F, Yung W, Zhou Y. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Cancer Res 2006;66(20):9809-9817.
18. Jemal A, Siegel R, Ward E, Hao YP, Xu JQ, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008;58(2):71-96.
19. Schinner S, Dellas C, Schroder M, Heinlein C, Chang C, Fischer J, Knepel W. Repression of glucagon gene transcription by peroxisome proliferator- activated receptor gamma through inhibition of Pax6 transcriptional activity. J Biol Chem 2002; 277(3):1941-1948.
20. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinomaof the prostate. CA Cancer J Clin 1972;22(4):232-240.
21. Roy-Burman P, Tindall DJ, Robins DM, Greenberg NM, Hendrix MJ, Mohla S, Getzenberg RH, Isaacs JT, Pienta KJ. Androgens and prostate cancer: Are the descriptors valid? Cancer Biol Ther 2005;4(1):4-5.
22. Denis L, Murphy G. Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer. Cancer 1993;72(12 Suppl):3888-3895.
23. Sadar M, Hussain M, Bruchovsky N. Prostate cancer: Molecular biology of early progression to androgen independence. Endocr Relat Cancer 1999;6(4):487-502.
24. Bonkhoff H, Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model. Prostate 1996;28(2):98-106.
25. Schoenmakers E, Verrijdt G, Peeters B, Verhoeven G, Rombauts W, Claessens F. Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem 2000;275(16):12290-12297.
26. Mizokami A, Yeh S, Chang C. Identification of 3′,5′-cyclic adenosine monophosphate response element and other cisacting elements in the human androgen receptor gene promoter. Mol Endocrinol 1994;8(1):77-88.
27. Altuwaijri S, Lin H, Chuang K, Lin W, Yeh S, Hanchett L, Rahman M, Kang H, Tsai M, Zhang Y, Yang L, Chang C. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate- induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Cancer Res 2003;63(21):7106-7112.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25(4):402-408.
29. Dai Y, Ngo D, Forman LW, Qin DC, Jacob J, Faller DV. Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Mol Endocrinol 2007;21(8):1807-1821.
30. Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 2005;65(4):1164-1173.
31. Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL, French FS. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res 1998; 58(24):5718-5724.
32. Sun Z, Pan J, Balk SP. Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 genes. Nucleic Acids Res 1997;25(16):3318-3325.
33. Salem C, Liang G, Tsai Y, Coulter J, Knowles M, Feng A, Groshen S, Nichols P, Jones P. Progressive increases in de novo methylation of CpG islands in bladder cancer. Cancer Res 2000;60(9):2473-2476.
34. Goudreau G, Petrou P, Reneker LW, Graw J, Loster J, Gruss P. Mutually regulated expression of Pax6 and Six3 and its implications for the Pax6 haploinsufficient lens phenotype. Proc Natl Acad Sci USA 2002;99(13):8719-8724.
35. Simpson T, Price D. Pax6: A pleiotropic player in development. Bioessays 2002;24(11):1041-1051.
36. Kozmik Z. Pax genes in eye development and evolution. Curr Opin Genet Dev 2005;15(4):430-438.
37. Hevner R, Hodge R, Daza R, Englund C. Transcription factors in glutamatergic neurogenesis: Conserved programs in neocortex, cerebellum, and adult hippocampus. Neurosci Res 2006;55(3) :223-233.
38. Mayes D, Hu Y, Teng Y, Siegel E, Wu X, Panda K, Tan F, Yung W, Zhou Y. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Cancer Res 2006;66(20):9809-9817.
39. Liao X, Thrasher J, Pelling J, Holzbeierlein J, Sang Q, Li B. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 2003;144(5):1656-1663.
40. Cooke PS, Young P, Cunha GR. Androgen receptor expression in developing male reproductive organs. Endocrinology 1991; 128(6):2867-2873.
41. Sato N, Sadar M, Bruchovsky N, Saatcioglu F, Rennie P, Sato S, Lange P, Gleave M. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J Biol Chem 1997;272(28):17485-17494.
42. Palvimo J, Reinikainen P, Ikonen T, Kallio P, Moilanen A, Janne O. Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 1996;271(39):24151-24156.
43. Aarnisalo P, Palvimo J, Janne O. CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci USA 1998;95(5):2122-2127.
44. Yuan X, Lu M, Li T, Balk S. SRY interacts with and negatively regulates androgen receptor transcriptional activity. J Biol Chem 2001;276(49):46647- 46654.